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ABSTRACT 
Oncogene activation disturbs cellular processes and accommodates a complex 
landscape of changes in the genome that contribute to genomic instability, which 
accelerates mutation rates and promotes tumourigenesis. Part of this cellular turmoil, 
involves deregulation of physiological DNA replication, widely described as 
replication stress. Oncogene-induced replication stress is an early driver of genomic 
instability and is attributed to a plethora of factors, most notably aberrant origin firing, 
replication-transcription collisions, reactive oxygen species and defective nucleotide 
metabolism.  
 
Significance 
Replication stress is a fundamental step and an early driver of tumourigenesis and 
has been associated with many activated oncogenes. Deciphering the mechanisms 
that contribute to the replication stress response may provide new avenues for 
targeted cancer treatment. In this review, we discuss the latest findings on the DNA 
replication stress response and examine the various mechanisms through which 
activated oncogenes induce replication stress. 
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INTRODUCTION 
Genomic instability (GIN) has been highlighted as a driving force of 
tumourigenesis by Hanahan and Weinberg in their celebrated ‘Hallmarks of cancer’ 
paper (1). GIN can result from changes in the number or structure of chromosomes 
(chromosomal instability), changes in the number of oligonucleotide repeats in 
microsatellite sequences (microsatellite instability), or base pair mutations, all of 
which are associated with activated oncogenes. Deregulation of DNA replication, 
known as replication stress (RS), is linked to GIN and is increased during the early 
steps of carcinogenesis (2-4). In particular, RS has been associated with 
chromosomal instability (5) as well as activation of the APOBEC3 family of 
deaminases (6) which increase the mutagenic load that fuels tumourigeneseis. In 
this review, we cover the latest findings on the RS response and discuss in detail the 
various mechanisms through which oncogenes induce RS.  
 
DNA REPLICATION  
DNA replication ensures the precise duplication of DNA during each cell cycle. It 
is a tightly regulated process that consists of two stages: licensing and initiation 
(reviewed in ref. 7). In eukaryotic cells, the licensing stage is restricted during late 
mitosis and G1-phase when thousands of replication origins are established along 
the genome and ensures that DNA replication occurs only once per cell cycle. For an 
origin to form, the origin recognition complex (ORC) binds at the origin site and 
recruits CDT1 and CDC6, which in turn facilitate loading of the mini-chromosome 
maintenance 2-7 (MCM2-7) helicases to form the pre-replicative complex (pre-RC) 
(Fig. 1A).  
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Cell cycle progression is controlled by cyclin dependent kinases (CDK) and the 
retinoblastoma/E2F pathway. CDK activity depends on binding to their regulatory 
subunits, cyclins, whose levels are regulated throughout the cell cycle by the 
anaphase promoting complex/cyclosome (APC/C). APC/C activity is high from late M 
to late G1-phase, hence CDK activity oscillates accordingly, being low during G1 and 
high during S/G2-phases. Mitogenic signalling by RAS triggers CYCLIN D/CDK4 to 
phosphorylate retinoblastoma, which renders it inactive, thus alleviating its inhibitory 
effect on the E2F family of transcription activators. E2F proteins promote expression 
of CYCLIN A and E, amongst other key S-phase genes, which upon binding to CDK2 
during G1/S-phase partake in promoting entry into S-phase.  
Replication initiation occurs as the cell proceeds into S-phase and requires the 
concerted action of CDK2 and DBF4/DRF1-dependent CDC7 kinases, which 
phosphorylates the pre-RC allowing recruitment of CDC45 and the GINS complex, 
and leads to the activation of the replicative helicase (CMG complex). Once this 
occurs, a replication bubble is formed and replication forks proceed bi-directionally 
from the origin (Fig. 1A). Under normal conditions, an excess of origins is licensed 
but only a small number of them becomes activated, with the remaining dormant 
origins reserved as a backup.  
  
THE DNA REPLICATION STRESS RESPONSE 
Replication is susceptible to impediments in DNA caused by both exogenous and 
endogenous DNA damaging agents and by the intrinsic properties of certain DNA 
sequences to adopt secondary structures. In particular, fork progression can be 
hindered due to interference with the transcription machinery, torsional stress or non-
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B DNA structures (cruciforms, hairpins, trinucleotide repeats, R-loops, G-
quadruplexes). 
 
The ATR/CHK1 pathway 
In response to RS, the cell initiates a DNA damage response (DDR) with the aim 
of resolving the damage or DNA secondary structures and restore fork progression 
(reviewed in ref. 8). During replication fork stalling, uncoupling between the 
replicative helicase and polymerase leads to the accumulation of single strand DNA 
(ssDNA) which is bound by RPA. ssDNA-RPA in turn allows the recruitment of the 
ATR kinase through ATRIP, as well as RAD17-RFC and RAD9-RAD1-HUS1 (9-1-1). 
The 9-1-1 complex also interacts with TOPBP1, which triggers ATR-ATRIP kinase 
activity, leading to the phosphorylation of numerous down-stream factors that 
collectively respond to RS. Recently, ETAA1 was identified as a novel RPA binding 
protein that activates ATR in response to DNA damage in parallel to 
TOPBP1/RAD17/9-1-1, and is involved in fork restart (9, 10). Τhe synergistic action 
of the TIMELESS/TIPIN complex promotes binding of CLASPIN to RPA, which 
allows ATR to phosphorylate its primary substrate kinase, CHK1, at Ser-317 and 
Ser-345. Additionally, ATR phosphorylates histone Η2ΑΧ at Ser-319 (γH2AX) early 
in the response. This modification then spreads away from the stalled fork, and is 
further sustained by two other DDR kinases ATM and DNA-PKcs. 
CHK1 organises the cellular DDR by inducing cell cycle arrest, inhibiting late 
origin firing, activating dormant origin firing, and promoting fork stabilization and fork 
restart (Fig. 1B). Cell cycle arrest allows sufficient time for the cell to effect lesions 
repair and also prevent premature entry into mitosis with under-replicated DNA. In 
response to stress, CHK1 phosphorylates CDK activators CDC25A/C, which leads to 
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their degradation or nuclear export, thus triggering arrest at S, G2 or G2/M-phases. 
At the same time, CHK1 phosphorylates and activates the CDK antagonist WEE1 
causing G2 delay.  
During unperturbed early S-phase, ATR protects the genome from ssDNA 
formation by inhibiting origin firing and promoting nucleotide synthesis at the same 
time (11). In general, ATR regulates origin firing by phosphorylating MLL at Ser-516, 
stabilizing it on chromatin where it methylates histone H3K4, inhibits CDC45 loading 
and blocks origin activation (12). Additionally, CHK1 regulates replication initiation by 
binding and phosphorylating TRESLIN, which inhibits CDC45 loading onto origins 
(13). Recently, a backup pathway of CHK1 activation was identified, when upon ATR 
inhibition, accumulation of ssDNA produces aberrant DNA structures, that after 
processing by SLX4-MUS81 induce a DNA-PK-dependent CHK1 activation that 
inhibits origin firing (11). 
In order to complete DNA replication in response to any disturbance, CHK1 
inhibits origin firing at new replication factories (late origins), while at the same time 
allows the firing of dormant origins within active replication factories that experience 
stress (14, 15) (Fig. 1B).  
 
Replication fork stabilization and reversal 
Stabilization of the replication fork has long been considered a CHK1 response to 
RS, protecting it from deleterious nucleolytic processing. This view has been 
challenged recently by evidence from yeast, showing that fork stability is retained in 
the absence of checkpoint kinases (16). In addition, a SILAC-iPOND study in human 
cells, revealed ATR to be responsible for fork but not replisome stability in response 
to RS and that ATR protects the fork from various forms of collapse (17). Notably, 
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RS at an active fork triggers accumulation of homologous recombination proteins, 
whereas RS arising in the context of an origin that fired due to a checkpoint 
deficiency triggers accumulation of non-homologous end joining proteins (17).  
A common mechanism of fork stabilisation involves the annealing of the parental 
DNA strands, followed by binding of the newly synthesized strands, thus forming a 
reversed fork structure, also known as regressed fork or a ‘chicken foot’ (Fig. 1B). 
Early studies in S. cerevisiae, showed that reversed forks accumulate in response to 
checkpoint defects (18), which led to the view that fork reversal is a pathological 
response. However, an expanding body of evidence has shown that reversed forks 
are also important for fork stability and protection from collapse. Reversed forks are 
formed through the action of many proteins, including RAD51 (19), PARP1 (20), 
BLM (21), WRN (22), SMARCAL1 (22), FANCM (23), FBH1 (24), HLTF (25) and 
ZRANB3 (26) and are favoured by positive supercoiling. Reversed forks are 
protected by BRCA1/2 (27), RAD51 (27), TOP1 (20), FANCA/B (28), FANCD2 (28), 
REV1 (29), WRN (30), BOD1L (31), RECQL5 (32) and WRNIP1 (33), in whose 
absence they are susceptible to the activity of nucleases MRE11 (27), DNA2 (34) 
and EXO1 (35) or resolvase Yen1 (36). Despite its positive role in resolving stalled 
forks, if unrestrained, fork reversal can cause fork collapse (37), highlighting the 
need for a regulated balance between reversal and restart. 
 
Replication fork restart 
Once a fork is stalled, different pathways, including homologous recombination, 
re-priming, template switching, translesion synthesis and break-induced replication 
may occur to allow replication restart (Fig. 2). The details of these mechanisms have 
been described elsewhere (38) and are not the focus of this review. Alternatively, 
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stalled forks may be resolved by an incoming fork from an adjacent origin. Evidence 
in yeast has shown that terminally arrested forks that are unprotected by 
Rad52/Rad51, cannot merge with a converging fork and appear in the ensuing 
mitosis as anaphase bridges (39). If fork stalling is sustained the forks often collapse 
into double strand breaks (DSBs) by the combined nucleolytic activities of SLX4 and 
nucleases MUS81-EME1, XPF-ERCC1 and EXO1 (reviewed in ref. 40). 
Recent insights from the Hickson and Halazonetis labs discovered how under-
replicated DNA is managed if it escapes replication/repair during S-phase. According 
to their data, regions of under-replicated DNA are processed by MUS81-EME1 
during G2 and with the help of RAD52, POLD3 polymerase and SLX4-MUS81 
perform mitotic DNA synthesis (MiDAS) to repair the collapsed forks (41-43). 
Furthermore, RECQL5 helicase is recruited to common fragile sites (CFSs) by 
MUS81 to remove RAD51 filaments from stalled replication forks to allow processing 
by MUS81-EME1 and enable MiDAS (44). Lack of MiDAS increases 53BP1 bodies, 
anaphase bridges and chromosomal rearrangements, promotes tumour growth and 
sensitizes cells to aphidicolin (41-43) (Fig. 2).  
 
Targeting replication stress for cancer treatment 
Importantly, RS can be exploited for cancer cell killing and thus has been 
described as an Achille’s heel of cancer. ATR or CHK1 inhibition induces RS and 
synthetic lethality in CYCLIN E (45), c-MYC (46) and H/K-RAS (47) overexpressing 
cells, as well as MYC-induced lymphomas (48), MLL-ENL or NRAS-driven acute 
myeloid leukaemias and HRAS-expressing fibrosarkomas (46). Furthermore, WEE1 
inhibition confers synthetic lethality in H3K36me3-deficient cancer cells by instigating 
deoxyribonucleoside triphosphate (dNTP) starvation and RS (49). In an intriguing 
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recent report, a combination of ATR and CHK1 inhibitors, result in fork slowing, 
replication catastrophe and synthetic lethality in cells overexpressing HRASV12 or c-
MYC and in other cancer cell lines (50). In this case, CHK1 inhibition causes 
increased CDK-dependent origin firing that depletes dNTP pools, leading to fork 
slowing and ssDNA accumulation that is normally protected by an ATR-dependent 
deposition of RPA; the subsequent ATR inhibition deprotects the forks and kills the 
cell (50).  
Reversing RS as a strategy to alleviate its tumourigenic effect has proven to be 
more complicated, as an extra CHK1 allele can reduce RS but surprisingly increases 
transformation (51). Nevertheless, replication fork stability is a significant contributing 
factor to chemotherapeutic drug resistance. This is exemplified by the fact that 
alleviation of MRE11-dependent GIN upon treatment with replication poisons in 
BRCA-deficient cells, by loss of PTIP, CHD4 or PARP1 confers synthetic viability 
and chemoresistance (52). All of the above, highlight the importance of RS as a 
hallmark and driver of cancer.  
 
ONCOGENES 
Normal cells become cancerous through a complex process known as oncogenic 
transformation. Transformation is driven by altered expression of oncogenes, tumor 
suppressors or microRNAs that derail their normal physiological function (reviewed 
in ref. 53). A proto-oncogene is a gene that under unperturbed conditions generally 
encodes a protein implicated in cell growth, differentiation or apoptosis. Either 
through point mutation, chromosomal translocation or copy number amplification, 
expression of the proto-oncogene is misregulated resulting in an activated 
oncogene. Oncogenes are translated into oncoproteins, which are classified as 
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growth factors, growth factor receptors, transcription factors, signal transducers, 
chromatin remodelers and apoptosis regulators. As such, oncogene activation may 
cause massive changes in the genome by deregulating cell cycle, metabolism, 
replication-timing or transcription, which ultimately drive GIN. 
The principle mechanisms through which GIN is induced in cancer involve DNA 
repair defects, heightened replication stress and telomeric dysfunction (Fig. 3A). In 
hereditary cancers, GIN is commonly attributed to germline mutations in genes 
involved in DNA damage repair. These mutations give rise to unrepaired or 
inaccurately repaired DNA that lead to GIN (reviewed in ref. 54). Certain oncogenes 
can also cause a similar DNA repair defect. In particular, overexpression of 
oncogenic RAS and BRAF cause dissociation of BRCA1 from chromatin, which 
compromises DSB repair leading to DNA damage and senescence (55). 
Furthermore, wild type HRAS and NRAS modulate DDR to support the tumorigenic 
activity of oncogenic KRAS (56).  
Oncogenes can also induce DNA replication defects and under-replicated DNA, 
which leads to accumulation of mutations and GIN. RS manifests in various forms, 
the most obvious being perturbed fork extension rates and/or heighted fork 
stalling/collapse, which may prevent complete replication of the genome. Such sites 
are marked by 53BP1 (57) and often correspond to CFSs, which are more 
susceptible to breakage by MUS81-EME1 or XPF-ERCC1. Replication through 
CFSs is exacerbated by mild RS, partly due to the absence or aberrant activation of 
dormant origins within these regions (58). During chromosomal segregation in 
mitosis, under-replicated regions often present as ultra-fine anaphase DNA bridges 
(UFBs) (59) that are bound by PICH, BLM and RPA with FANCD2 associated with 
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their extremities. Unresolved UFBs may lead to chromosome breakage and/or mis-
segregation, resulting in micronuclei formation in daughter cells (59). 
Finally, telomeric dysfunction can also lead to GIN. Telomeres are comprised of 
repeated sequences that maintain and protect chromosome ends from deleterious 
processing and/or unscheduled DNA repair. With each cell cycle, telomere repeats 
progressively shorten due to the ‘end-replication problem’, oxidative damage and RS 
associated with oncogenic activation. Telomeric dysfunction is linked to extended 
chromosomal shattering and rearrangements known as chromothripsis and kataegis, 
which drive GIN in cancer (60). Telomeric erosion is counteracted by the expression 
of telomerase that synthesizes de novo telomeric repeats at chromosome ends. 
Reports that HPV 16E6/E7-induced anaphase bridges (61) and oncogene-induced 
senescence (62) are ameliorated upon activation of telomerase activity, highlight the 
connection between telomeric integrity and GIN. Additionally, HRAS causes 
telomeric fork stalling, as well as telomeric fragility and loss of telomere repeats (63). 
Therefore, telomeric erosion can be linked to oncogene-induced telomeric replication 
stress, although it can also be attributed to oncogene-induced telomerase 
deregulation (61).  
Apoptosis and senescence act as protective mechanisms that eliminate or halt 
cells that present with RS and/or GIN. This cancer protection barrier is quite robust 
as affirmed by the fact that expression of oncogenes alone does not lead to 
oncogenic transformation, unless combined with other genetic events, most notably, 
additional expression of other oncogenes or mutation of tumour suppressor genes 
(64-66). Oncogene-induced senescence is ascribed to the actions of the tumour 
suppressor p53 and its positive regulator p14/p19 (ARF). ARF inhibits the ubiquitin 
ligase MDM2 that is normally responsible for p53 degradation, thereby stabilizing 
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p53 levels. Amongst other oncogenes, p53 is activated in response to RAS, c-MYC, 
E1A and STAT5A overexpression either directly through ARF or RS-induced ATM 
activation. In addition, oncogenes RAS, MYC, E2F1, β-CATENIN and adenovirus 
E1A have been shown to upregulate ARF, while c-MYC causes ARF stabilization by 
inhibiting its ubiquitylation and subsequent degradation by ULF ubiquitin ligase 
(reviewed in ref. 67). 
Of the 803 identified oncogenes in the ONGene database (http://ongene.bioinfo-
minzhao.org/) only 27 have been assessed for their impact on RS, the majority of 
which are most commonly activated in human cancers. Additionally, for those 
oncogenes that have been studied there is variability in how RS is driven (Table 1). 
The concept that different oncogenes induce RS through different mechanisms is 
supported by many reports. In particular, RAS and CYCLIN E create unique 
landscapes of fragile sites that differ to the sites induced by aphidicolin treatment, 
which inhibits replication (68). Overexpression of CYCLIN E, but not A or D1, 
induces chromosomal instability in human cells (69). Overexpression of CYCLIN E 
and CDC25 also cause fork slowing and replication fork reversal at the same time 
point, but DSB formation and DDR signalling exhibit vastly different kinetics (70). It is 
worth noting that not all oncogenes lead to fork stalling, as exemplified by DEK that 
promotes fork progression under RS conditions (71) and E1A (72), SPI1/PU.1 (73) 
and LMO2 (74) that increase fork speed. 
 
MECHANISMS OF REPLICATION STRESS INDUCTION BY ONCOGENES 
In the following section, we will discuss the various mechanisms through which 
oncogenes induce RS. 
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Origin firing dysregulation 
As mentioned earlier, replication is a fine-tuned process that ensures faithful DNA 
duplication once and only once per cell cycle. Dysregulation of CDK activity or 
mutations in the retinoblastoma/E2F pathway lead to perturbation of licensing or 
initiation, which in turn cause the unscheduled firing of origins. This may involve 
increased or decreased firing or re-firing of the same origin, all of which compromise 
physiological fork progression and lead to cells entering mitosis bearing under- or 
over-replicated DNA that eventually leads to GIN. 
Different origins are activated at different time points during S-phase and 
modulation of CDKs affect the number of replication clusters rather than the origins 
within them (75). Interestingly, the level of origin firing inversely correlates with the 
rate of replication fork progression, which is believed to reflect the availability of 
essential replication factors (76). Under physiological conditions, origin firing is 
regulated by ATM and ATR by controlling CDK2 and CDC7 through CDC25A (77). 
CHK1 is crucial in this regulation, as its inhibition increases origin firing and leads to 
RS (78).  
 
Decreased firing 
Inhibition of DNA licensing reduces origin firing and induces GIN and increased 
sensitivity to RS-inducing agents (79). Compromised MCM loading due to reduced 
CDT1, CDC6 and ORC or increased CDT1 inhibitor GEMININ may hinder licensing. 
In the absence of functional p53, inhibition of DNA licensing in cancer cells allows 
their entry into S-phase with reduced origin firing (80). Similarly, ORC1 deletion 
reduces origin firing and increases sensitivity to hydroxyurea in tumour or MYC-
expressing cells (81), suggesting a possible therapeutic approach to target certain 
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cancers. Moreover, CDK deregulation in G1 through inhibition of Cdh1 and Sic1 
reduces origin firing and causes GIN (82). In addition, CDKs phosphorylate CDC6 
and protect it from APC/C-dependent proteolysis during G1 (83), thus disruption of 
this mechanism would enable licensing and perhaps origin firing during S-phase. 
Oncogenes have also been shown to affect replication origin licensing. In 
particular, MYC deregulates expression of both CDKs and E2Fs and modifies cell 
cycle progression (reviewed in ref. 84). On the other hand, there seems to be 
controversial data regarding CYCLIN E. In one report, CYCLIN E overexpression 
impairs MCM2, 4 and 7 loading onto chromatin during telophase and early G1, which 
reduces the number of active replication origins in early S-phase (85). In contrast to 
this, other groups have shown that CYCLIN E overexpression increases the number 
of origins firing in S-phase (86, 87). This discrepancy could be attributed to different 
properties of the cell lines used in these studies, as CYCLIN E can promote or inhibit 
pre-RC formation depending on cellular context (88). 
Intriguingly, decreased origin firing increases fork speed progression (76), raising 
the question of how this causes GIN. In mouse, Chaos3 is a viable mutation that 
destabilizes MCM4. MCM4Chaos3/Chaos3 MEFs exhibit a 60% reduction of all MCM2-7 
components, which does not affect origin firing but does reduce the number of 
dormant origins and increases fork speeds (89). Due to the inability of the cells to 
repair endogenous RS through firing of dormant origins, fork stalling occurs and RS 
markers such as γH2AX, pRAD17 and RPA are activated, suggesting that GIN can 
occur even in the absence of direct fork slowing (89). Following the same pattern, 
E1A expressing cells exhibit reduced origin firing and increased fork speeds (72). 
 
Increased firing 
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Untimely origin firing is the result of disruption of initiation control. This has been 
shown in X. laevis where increasing CDK activity accelerates the origin firing pattern 
(75), as well as in other systems where dysregulation of ATR, CHK1 or WEE1 that 
control CDK or CDC7 activity, cause extensive origin firing (90, 78, 77). 
Dysregulation of origin activation increases the possibilities of conflicts with 
transcription (87) and may lead to enhanced depletion of replication building blocks 
such as dNTPs (90, 86, 91), histones (92) or RPA (93), which hinder fork 
progression (Fig. 3B).  
Many oncogenes disrupt the physiological origin firing schedule. In particular, Di 
Micco et al. showed RAS to induce a hyper-proliferation phase accompanied by 
increased origin firing that contributes to RS (94). HPV E6/7 and CYCLIN E 
overexpression enhances origin firing leading to GIN (86), while c-MYC 
overexpression increases origin activity in a transcription-independent (95) but 
CDC45 and GINS-dependent manner (96). Interestingly, inhibition of origin firing 
failed to abrogate RAS-induced RS (97) but did rescue CYCLIN E–induced RS (98), 
which again hints at different mechanisms through which oncogene activation leads 
to RS. 
 
Re-firing 
Disruption of DNA licensing as well as CDK-dependent protective pathways 
enable re-replication events, which are associated with GIN and tumourigenesis 
(99). In particular, CDT1 (and to a lesser extent CDC6) overexpression induce re-
firing that leads to GIN (100), while depletion of GEMININ induces re-firing and 
activation of the DDR (101). Moreover, compromising the CUL4-DDB1 ubiquitin 
ligase, which regulates CDT1 (102) or loss of EMI1 that indirectly regulates 
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GEMININ, also leads to re-replication (103). The ATR-dependent S-phase 
checkpoint surveys the genome and prevents re-replication caused by 
overexpression of licensing factors (but not GEMININ loss), either through p53-
dependent activation of p21 or through dephosphorylation of retinoblastoma (104, 
101, 100). Circumventing the retinoblastoma/E2F pathway is another way to 
instigate re-replication and CYCLIN E and c-MYC facilitate this (105), while HPV E7 
ubiquitinates retinoblastoma marking it for degradation (106). 
The main consequences of origin re-firing entail the so-called head-to-tail 
collisions that occur between the leading strand of the secondary fork and unligated 
Okazaki fragments of an adjacent fork, that cause DSBs and DNA damage 
checkpoint activation (99). Deregulated origin firing produces ssDNA gaps that 
promote re-replication at these sites, leading to replication fork breakage (107). Re-
replication also causes fork slowing, although it is not clear if this is a consequence 
of head-to-tail collisions or due to normal forks colliding with the re-replication-
induced DSBs. Overexpression of oncogenic RAS, CYCLIN E or MOS upregulate 
CDC6 (2, 94, 83) and in the case of RAS this causes re-replication (94). 
Furthermore, overexpression of a constitutively nuclear mutant form of CYCLIN D1 
induces CDT1 stabilization that promotes re-licensing and re-replication (108).  
 
Transcription 
Transcription-replication conflicts 
DNA transcription is a physiological process that may turn into an intrinsic source 
of GIN upon interference with the replication fork machinery. Transcription-replication 
conflicts (TRCs) impede replication fork progression as a result of head-on or co-
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directional collisions between the two machines or between replication and R-loops 
(Fig. 4). 
TRCs were first visualized by electron microscopy in E. coli, where an inducible 
origin was inserted upstream or downstream of an rRNA operon (109). Organisms 
have developed various strategies to avoid interactions between the two systems. In 
prokaryotes, where DNA is circular and there is a single origin of replication, co-
orientation of the replisome and the transcription machinery is highly favoured (110). 
A similar orientation bias was also described in the human genome (111). In order to 
regulate replication through parts of the genome that are highly transcribed or 
difficult to replicate, both prokaryotes and eukaryotes have developed replication fork 
barriers comprising proteins bound tightly to DNA, which serve to limit TRCs. In 
eukaryotes where replication is mediated through multiple origins, transcription takes 
place throughout the cell cycle and is regulated spatially and temporally so that it 
does not clash with replication (112). Furthermore, in budding yeast, tRNA gene 
transcription is restrained during S-phase by Mec1/Mrc1/Rad53 in order to avoid 
collision with the replication machinery (113). RNApolII has a unique role in 
preventing and resolving TRCs, although it is not clear how this is achieved (114). 
Also, in E. coli the transcription factor DksA interacts with RNA polymerase (RNAP) 
and by altering the transcription elongation complex it prevents TRCs upon nutrition 
stress (115). 
During transcription, RNAP may pause either as part of a regulatory checkpoint 
(promoter-proximal pausing) or in response to obstacles or misincorporated 
nucleotides that cause stalling and polymerase backtracking. Backtracking events 
involve RNAP sliding back and forth across DNA, which dislodges the 3’OH end of 
the RNA from the RNAP active site allowing it to exit through a secondary channel. 
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Backtracked RNAPs can hinder replication, as well as transcription, and cause GIN 
(116) (Fig. 4C, D). To deal with arrested or backtracked RNAPs, cells employ 
various strategies, such as i) cleavage of the misplaced RNA transcript by GreA/B or 
TFIIS, ii) reduction of misincoroporated nucleotides by DksA, iii) RNAP removal by 
the combined actions of ppGpp, DksA, GreA and Mfd or UvrD and NusA (reviewed 
in ref. 117) or iv) transcription regulation by RECQL5 (118). 
 
R-loops 
R-loops are DNA:RNA hybrids that are formed during transcription, when the 
newly synthesized RNA remains tangled around the template DNA, while the 
homologous ssDNA is displaced. Mapping of R-loops in mammals revealed that their 
formation is prevalent, conserved and dynamic across the genome and is favoured 
by increased transcription activity, polyA tracts and unmethylated CpG islands 
(reviewed in ref. 119). Information on R-loop forming sequences across the genome 
of various species can be found online at R-loopDB (http://rloop.bii.a-star.edu.sg). R-
loops associate with specific epigenomic signatures at promoters and terminators 
and are involved in mitochondrial replication (120), transcription regulation (121), IgG 
class switch recombination (122), telomere maintenance in ALT cells (123) and 
homologous recombination-mediated DSB repair (124). Nevertheless, accumulation 
of R-loops can act as an obstacle to replication fork progression either through direct 
collisions (125) or indirectly through increased chromatin compaction (126), which 
leads to CFS formation (127) and GIN (128) (Fig. 4G). The ssDNA part of R-loops 
renders DNA more susceptible to DNA damaging agents, such as activation-induced 
cytidine deaminase (AID), which regulates class switch recombination and somatic 
hypermutation in mammalian B cells (reviewed in ref. 129). AID deaminates cytidine 
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only in ssDNA with base or nucleotide excision repair of these alterations, giving rise 
to mutations, chromosomal translocations or breaks that in turn may facilitate 
oncogenic activation.  
R-loops may inhibit transcription progression (130) and consequently either on 
their own or through stalled or backtracked RNAPs act as additional barriers to 
transcription or replication (Fig. 4D). Their length may vary from a few hundred to 
over 1 kb and recent evidence in S. cerevisiae show that it is not length but histone 
modifications that discriminate between ‘benign’ and ‘malignant’ (131). In particular, 
Garcia-Pichardo et al. proposed a two-step model, where at first R-loop formation is 
facilitated by an altered chromatin configuration, followed by chromatin modifications 
(including H3S10 phosphorylation (126)) that render them culpable for GIN (131). In 
addition, experiments in Drosophila showed that depletion of linker histone H1 
facilitates transcription of heterochromatic transcripts enabling R-loop accumulation 
(132). Similarly, in C. elegans, H3K9 methylation suppresses transcription of 
repetitive elements that enhance R-loops (133). Despite the acquired knowledge of 
R-loop-induced GIN, the exact mechanisms behind it still remain elusive. 
R-loops are regulated by a plethora of molecules. In particular, RNaseH1 (128), 
RNaseH2 (134), SETX (135), DDX19 (136), DDX21 (137), DDX23 (138), DinG (139) 
and Pif1/Rrm3 helicases (140) degrade or unwind R-loops. ASF/SF2 (141), TOP1 
(142), RECQ5 (143), THO/TREX (130), Npl3 (144), AQR (145) and XRN2 (146) 
prevent R-loop formation. Also, BRCA1/2 (147) and Fanconi anaemia proteins 
remove R-loops (148) while BRCA1 forms a complex with SETX at transcription 
termination pause sites, which collaborate to suppress R-loop accumulation (149). In 
addition, the chromatin reorganizing complex FACT facilitates resolution of R-loop-
dependent GIN, most likely through remodelling chromatin at the sites of conflict 
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(150). Moreover, introns were recently identified as an unexpected source of R-loop 
regulation, as their presence within highly transcribed regions of yeast or human 
genomes protects against R-loop accumulation and DNA damage (151). 
Since oncogenes enhance transcription, it is reasonable that they should also 
affect R-loop levels. Only recently, HRASV12 overexpression was shown to increase 
R-loop accumulation that was detrimental to fork progression (97). As part of the 
same study, HRASV12 caused stabilization of RNAseH1, which can be interpreted as 
an intrinsic response to increased R-loop levels. Likewise, CYCLIN E-induced RS 
was rescued upon RNaseH1 overexpression (87). 
 
Orientation of transcription-replication conflicts 
Orientation of TRCs has a profound effect on DNA integrity. Studies in yeast have 
shown that head-on collisions are more detrimental than co-directional ones with 
respect to fork slowing (152). Nevertheless, co-directional collisions also disrupt 
replication (153). Moreover, in bacteria co-directional collisions with backtracked 
transcription complexes cause DSBs, while head-on collisions do not (116). Further 
experiments in bacteria have shown that with both types of collision, the replisome 
resumes elongation after displacing RNAP from the DNA and in the case of co-
directional collision it uses the nascent transcript as a primer (reviewed in ref. 154). 
Using a sophisticated episomal system to induce either head-on or co-directional 
TRCs, Hamperl et al. showed in human cells that replication itself modulates R-loop 
formation depending on the orientation of the TRC. In particular, co-directional TRCs 
resolve R-loops and activate the ATM-CHK2 pathway, while head-on conflicts 
between replication and an R-loop (but not an R-loop-less transcription machinery) 
promote R-loop accumulation and activation of the ATR-CHK1 pathway (125). They 
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also showed that normal replication fork progression suppresses R-loop 
accumulation, so any type of fork slowing increases R-loop levels (125). According to 
their proposed model, head-on TRCs cause fork slowing, which leads to increased 
R-loops levels that in turn activate ATR, while co-directional TRCs resolve R-loops, 
but the replisome may collide with backtracked RNAPs left by the R-loops that 
causes DSBs and ATM activation. Similar results were obtained in B. subtilis, where 
head-on TRCs induce R-loop formation, which stall replication, increase 
mutagenesis and prevent fork restart (155). These findings were further corroborated 
in S. cerevisiae, where in unchallenged conditions, a mutation in the MCM2-7 
complex modulates replication and causes accumulation of R-loops in S-phase 
(156). Taken together, these data disclose a conserved and complex mechanism 
that protects the genome from TRC-related GIN. 
 
Topological stress 
Topological constraints may also develop between the replication and 
transcription machines as they move along DNA, causing positive or negative 
supercoiling, that may act as an obstacle to fork progression (157) (Fig. 4E). 
Furthermore, it has been suggested that nascent RNA can become tangled around 
template DNA and form a loop during nuclear export (Fig. 4F). These loops can 
obstruct the release of torsional stress from incoming replication forks and thus 
impede fork progression (158). Torsional stress is released by the activity of 
topoisomerases I and II, which relax positive supercoiling by creating nicks in DNA 
(159). RECQ5 facilitates SUMOylation of TOP1 which enables TOP1 binding to 
RNAPolII and at the same time compromises its activity, indicative of a regulatory 
mechanism of TOP1-induced genotoxicity (143). Also, in yeast Mec1 and Rad53 
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phosphorylate nucleoporin Mlp1 and resolve the topological stress (158). Finally, 
according to a recent study, p53 loss causes stabilization of TOP2A on DNA, as well 
as fork retardation, suggesting a possible role in preventing torsional stress between 
the two machines (160). 
 
G-quadruplexes 
G-quadruplexes are four-stranded structures held by G-G base pairs that are 
formed co-transcriptionally and impede replication fork progression leading to 
breakage (Fig. 4H). G-quadruplexes can form within the displaced ssDNA part of an 
R-loop of an active transcription bubble (161), where they facilitate R-loop 
stabilization (162). G-quadruplexes are also found within start sites of highly 
transcribed genes such as MYC (163), KRAS (164) or PTEN and regulate 
transcription (165). Moreover, the ORC complex has been suggested to bind to G-
quadruplexes at putative origin sites of replication initiation (166). In order to avoid 
potential collisions with the replication machinery, helicases such as Pif1, RTEL1 or 
DHX9 bind G-quadruplexes and unwind them to maintain genomic stability (reviewed 
in ref. 167). 
 
TRCs-associated DNA damage response 
Certain areas of the genome are more susceptible to TRCs. Barlow et al. 
identified highly unstable regions of the genome, named early replication fragile sites 
(ERFSs) that are more prone to breakage upon RS than CFSs (168). ERFSs are 
usually found within highly transcribed gene clusters and although they may break 
during normal replication, their fragility is increased in response to hydroxyurea-
induced RS, ATR inhibition, c-MYC expression or increased transcription (168). 
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Additionally, long genes are more prone to TRCs, with frequent R-loop accumulation 
and induction of CFSs instability (127).  
In response to DNA damage or TRCs, the cell tends to shut off transcription to 
reduce further collisions and facilitate replication restart. This is evident in yeast, 
where genotoxic-induced RS causes tRNA gene transcription repression by Maf1 
(113) and through the synergistic effect of checkpoint sensor Mec1-Ddc2, the 
chromatin remodelling complex INO80C and transcription complex PAF1C, RNAPolII 
is evicted from chromatin and degraded (169). Accordingly, Dcr1 releases RNApolII 
from highly transcribed genes that are sites of replication-transcription collisions to 
prohibit further instability (170). Moreover, in response to transcription-blocking DNA 
damage, R-loop-dependent ATM activation triggers spliceosome displacement from 
chromatin, causing widespread splicing changes that presumably facilitate DNA 
repair (171). Interestingly, the de Bruin lab has shown that the cell responds to RS 
by upregulating transcription of E2F target genes that maintain checkpoint activation 
and facilitate DNA damage tolerance (172, 173). These data suggest that there 
needs to be a fine tuning between decreasing deleterious transcription and retaining 
and/or upregulating levels of checkpoint proteins.  
Various proteins, especially helicases, preserve genomic stability by preventing or 
resolving TRCs. Amongst them, RECQL5 has a dual role in resolving conflicts 
between replication and RNApolI/RNApolII-dependent transcription by either 
promoting RAD18-dependent PCNA ubiquitination or through its helicase activity 
resolves RAD51-dependent replication intermediates at these sites (174). In S. 
pombe, Pfh1, a member of the Pif1 family of helicases, facilitates replication across 
highly transcribed RNApolII- and RNApolIII-dependent genes (175). Likewise, in S. 
cerevisiae, another Pif1 family member, Rrm3 allows replication through TRCs (152). 
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Moreover, in E. coli, helicases DinG, Rep and UvrD collaborate to promote 
replication through transcription units (139). 
In response to oncogenic signalling, transcription activity is enhanced (176-178, 
38, 179, 180) and collisions between replication and transcription are more likely to 
occur. This is usually attributed to point mutations in the promoter region of proto-
oncogenes that increase transcription activity. c-MYC is itself a transcription factor 
that under normal conditions drives a transcriptional programme that controls cell 
growth and division. Mitogenic growth signalling may deregulate c-MYC which can 
directly enhance RNApolI- (178), RNApolII- (179) and RNApolIII-dependent 
transcription (177). c-MYC increases transcription indirectly, by up- and/or 
downregulating selective target genes that in turn modify the cellular state and 
enable global RNA production (181). This transcription amplification has been 
documented in patient-derived tumours with elevated c-MYC thus establishing a link 
to tumorigenesis (179). CYCLIN E overexpression enhances both transcription 
activity and origin firing, causing increased TRCs and subsequent RS that can be 
rescued by either transcription or CDK inhibition (87). This is not the case with RAS 
overexpression, which causes RS, which can be rescued by transcription but not 
origin firing inhibition (97). RAS-induced enhanced transcription is driven through 
upregulation of transcription factors such as TBP, which is required for transcription 
of all promoters (97). Interestingly, overexpression of TBP alone causes RS, DNA 
damage, senescence and contributes to oncogenesis (182, 97). 
A very recent report shed light on the mechanisms underlying oncogene-induced 
TRCs and GIN. Using sensitive seq-based assays Macheret and Halazonetis 
mapped replication initiation sites in human cells (183). They showed that under 
physiological conditions, transcription suppresses intragenic origin firing, but upon 
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overexpression of CYCLIN E or MYC, G1-phase shortening drives earlier S-phase 
entry before completion of transcription. This allows origin firing within transcribing 
genes which leads to TRCs, fork collapse and DSB formation specifically at these 
sites. Moreover, this study revealed that fork collapse at oncogene-induced 
intragenic fired origins causes chromosomal translocations in a transcription-
dependent manner both in their experimental setup as well as in a large cohort of 
human cancers (183). This highlights the importance of TRCs amongst the other 
mechanisms in inducing GIN. 
 
Nucleotide metabolism 
Nucleotides are the building blocks of the replication machine, therefore any 
dysregulation of their structure or levels has an immediate effect on fork progression. 
In mammals, dNTPs are either synthesized through the de novo pathway in the 
cytoplasm or by recycling nucleosides and nucleobases from nucleotide degradation 
through the salvage pathway, which acts both in the cytoplasm and in mitochondria 
(Fig. 5). The crucial step in dNTP synthesis is the reduction of ribonucleoside 
diphosphates to deoxyribonucleoside diphosphates, which is catalysed by the 
ribonucleotide reductase (RNR). RNR is a tetrameric protein composed of two 
catalytic (RRM1) and two regulatory (RRM2, RRM2B) subunits. RRM2 levels are 
rate-limiting for RNR activity and consequently dNTP levels, so in order to retain 
balanced dNTP pools, RRM2 expression increases in S-phase and is low during G1, 
G2 and M-phases (184). There is increasing evidence that part of RNR associates 
with the replication fork and that in response to DNA damage RNR components re-
localize towards repair foci to increase dNTP availability (reviewed in ref. 185). In 
addition, ATR regulates dNTP pools by increasing RRM2 levels in response to DNA 
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damage (11, 49). Similarly, MEFs from mice carrying an extra allele of RRM2 display 
increased RNR activity, which reduces chromosomal fragility following ATR inhibition 
(186). 
dNTP levels are inversely related to origin firing and are key determinants of 
replication fork speed (90, 86, 91). Increased RNR activity accelerates fork 
progression, while reduced nucleotide pools instigate a transition to a slow 
replication mode with reduced origin usage, minutes after entry into S-phase (86, 
91). RRM2/RRM2B-induced increase in replication fork speed causes 
misincorporated uracil into DNA and breaks at fragile sites and it has been 
suggested that dUTPase can sanitize this to avoid GIN (187). Nevertheless, dNTPs 
need to be regulated within certain levels, as increased dNTP pools will cause 
aberrant replication and lead to mutations (188).  
With regards to the effect of oncogenes on nucleotide metabolism, BCL2 binds to 
RRM2 and disrupts the RRM1/RRM2 complex inhibiting RNR activity, which reduces 
nucleotide pool levels and leads to fork slowing (189). Moreover, overexpression of 
RAS downregulates RRM2 through binding of transcription repressor E2F7 to the 
RRM2 promoter, causing dNTP pool depletion, RS and senescence (190). In 
addition, CYCLIN E or HPV-16 E6/E7 overexpression activate cell proliferation but 
do not affect nucleotide biosynthesis, resulting in dNTP pool depletion and impaired 
fork progression (86). In contrast, c-MYC upregulates genes involved in nucleotide 
biosynthesis, increasing dNTP pools and enabling cell proliferation (191).  
Upon reduced dNTP levels, there is increased incorporation of ribonucleotides 
(rNTPs) into DNA during replication. Since rNTPs are more prone to hydrolysis than 
dNTPs, their integration into DNA affects fork progression and may lead to GIN. 
Misincorporated rNTPs can be detrimental to genomic stability, as depletion of 
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RNaseH2 that removes rNTPs causes RS (192). Despite the fact that there is no 
record of oncogenes promoting misincorporation of rNTPs on DNA, it seems quite 
likely that this may occur during the hyper-proliferation stage following oncogenic 
activation. 
The integrity of dNTPs is another critical factor that may cause GIN. Reactive 
oxygen species (ROS) can oxidize nucleotides that when incorporated into DNA 
trigger breaks, mutations and senescence (193). Oxidized dNTPs trigger fork 
slowing in X. laevis, but this is attributed to a protein kinase C-mediated reduction in 
DNA replication and not to an actual fork retardation (194). So, although it seems 
reasonable for oxidized dNTPs to cause fork slowing it still has not been shown 
definitively (Fig. 5). A hint towards this view lies with MTH1, which is a non-essential 
enzyme that sanitizes oxidized dNTPs, hindering them from being incorporated into 
DNA, thus preserving genomic integrity.  
 
Reactive oxygen species metabolism 
ROS are an assorted class of free radical species produced under normal 
conditions as byproducts of aerobic metabolism (reviewed in ref. 195). ROS include 
superoxide anion (O2
ˉ), hydrogen peroxide (H2O2) and hydroxyl radicals (OH•) and 
their biological effects are proportional to their levels. Basal ROS levels uphold 
physiological cellular functions as part of redox biology, while increased levels of 
ROS cause oxidative stress by damaging lipids, proteins and DNA or upregulating 
protein kinase Cδ and inducing senescence or apoptosis. O2
ˉ is produced either by 
oxidation of nicotinamide adenine dinucleotide phosphate (NADPH) by NADPH 
oxidase enzymes (NOXs) or through aerobic respiration in mitochondria. H2O2 is 
generated from O2
ˉ by superoxide dismutases and exerts its effect on redox biology 
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or oxidative stress or may be converted to H2O by antioxidant proteins. Finally, OH• 
are produced from H2O2 in the presence of Fe
+2 (196) (Fig. 5). 
Cancer cells exhibit abrupt alterations in their metabolism to support their rapid 
growth. These include ATP generation to maintain energy levels, increased 
synthesis of macromolecules and maintenance of cellular redox status. Oncogenes 
are known to induce ROS and cause DNA damage. Expression of activated RAS 
increases intracellular and mitochondrial ROS and leads to senescence (197), which 
is partially achieved by upregulating NOX4-p22phox (198). c-MYC overexpression 
also induces ROS and causes DNA damage (199). A comparative study between 
RAS and MYC showed that both oncogenes evoke changes in the cellular 
metabolism patterns and induce different degrees of oxidative stress and RS, 
highlighting again that different oncogenes follow different mechanisms to cause RS 
(200). Moreover, in response to KRASG12D, B-RAFV619E and MYCERT2 primary murine 
cells respond by upregulating transcription factor Nrf2 that regulates an antioxidant 
program used to detoxificate the organism (201). In addition, expression of E6/E7 
promotes NOX-dependent generation of ROS and subsequent DNA damage in head 
and neck cancer cells (202). 
It is unclear how ROS affect fork progression. According to the D’adda di Fagagna 
lab, RAS induces ROS and this triggers the hyper-proliferation that leads to RS and 
senescence (94, 197, 203). On the other hand, CYCLIN E-induced hyper-
proliferation is independent of ROS (2). Another case involves ROS oxidizing 
dNTPs, as was covered in the previous chapter. 
 
CONCLUDING REMARKS 
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Oncogene-induced RS has long been recognised as an early driver of cancer and 
investigating the mechanics of this process has been established as a field in its own 
right. Understanding RS has accelerated cancer diagnosis and assisted the 
development of more sophisticated anticancer treatments. Nevertheless, the 
mechanics of how oncogene activation lead to RS present a complicated 
kaleidoscope of intertwined pathways and to make matters worse, various 
oncogenes may differentially affect these pathways based on the cell type or the 
time point their effect is assessed. So, the consensus that different oncogenes exert 
a different effect at different time points needs to be more widely adopted.  
Despite the importance of each of the different mechanisms of oncogene-induced 
RS presented here, oncogene-induced deregulation of transcription appears to play 
the most significant role in cancer development, in part, due to its multifaceted nature 
in inducing GIN. The role of TRCs is especially intriguing, as currently little is known 
regarding the proteins and pathways involved in their detection and repair, as well as 
the implication of oncogenes in them. Although there is growing interest in R-loops 
and their involvement in GIN, there are a lot to be explored on their regulation and 
role in genome wide RS and telomere erosion and potential connections between 
them. Finally, there are still unanswered questions on the role of G-quadruplexes, 
rNTP missincorporation and oxidized nucleotides in oncogene-induced RS that need 
to be addressed.  
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oncogene 
genetic 
alteration 
effect on fork 
progression 
↑DSBs ↑ROS 
↑transcription 
/ R-loops 
affects 
nucleotide 
pools 
activates 
induces 
senescence 
γH2AX ATR ATM 
AKT-2 pm, oe   §204      §204 
AML1/ETO oe  205    205  205 205 
AURORA A oe ↓206        207 
β-CATENIN oe      208   208 
BCL-2 oe ↓189    189    209 
BCR/ABL oe, tr  210, 205 210, 211   X205  X205 205 
BRAF oe, pm   212  190 190   
190, 213, 212, 
214 
B-MYB kd ↓215 215    215   216 
CDC6 oe  217    3  3 3 
CDC5A oe ↓70 70    2, 218, 70 2, 70 2, 70  
CYCLIN D oe, tr, kd ↓108     108, 219 X219 108 220 
CYCLIN E oe ↓3, 86, 87, 70 3, 70  §87 86 
2, 3, 86, 87, 
70, 219 
2, 3, 70, 219 2, 70 3 
DEK kd ↑71 221    221, X71  X71 X71 216, 221 
E1A oe ↑72     72 X72 72  
E2F1 oe      2, 218, 222  218, 222 223, 222, 224 
EGFR oe   225   225   225 
HPV E6/E7 oe ↓86 226, 202 202  86 
86, 226, 224, 
219 
   
LMO1-4 oe, kd ↑74   176, 180      
MDM2 oe ↓227      227   
MOS oe  3    3  3 3 
MYC pm, oe ↓200, 96 228, 199 
200, 228, 
199 
177-179 191 229, 200, 96 229 228, 96 199 
MYH11/CBFB oe  X205    X205  X205 205 
NPM-ALK oe   230 231  232, 233 232 232 233 
RAS pm, oe ↓234, 97, 200 
97, 205, 
198 
197, 225, 
200, 203, 
198 
97 190 
190, 94, 97, 
225, 224, 200, 
203, 205, 198 
234, 94, 97, 
224 
224,94, 205 
 
190, 94, 225, 
224, 203, 66, 
205 
SPI-1/PU.1 oe ↑73 X73    X73    
STAT5A oe      224 224 224 224 
TAX oe ↓235 235, 236 236, 237   235, 236   236 
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TABLE LEGENDS 
Table 1. List of oncogenes and their effect on replication stress-related 
response. §: Indirectly, ↑: Positive effect, ↓: Negative effect, X: No effect, tr: 
translocation, pm: point mutation, oe: overexpression, kd: knockdown. 
 
FIGURE LEGENDS 
Figure 1. DNA replication and replication stress response. A, in late mitosis and 
throughout G1-phase, the pre-replicative complex comprised by the ORC complex, 
CDC6 and CDT1 is recruited to replication origins to facilitate loading of the MCM2-7 
complex. During G1-phase, retinoblastoma (Rb) is bound to E2F rendering it 
inactive. Phosphorylation of Rb by the Cyclin D-CDK4 complex alleviates its 
inhibitory effect on E2F. APC/C activity is high from late M- to late G1-phase 
regulating CDK activity. Upon entry in S-phase, APC/C is inhibited and CDKs are 
activated throughout S, G2 and early M-phase. CDKs form complexes with E2F-
regulated cyclins that collaborate with CDC7 to phosphorylate TRESLIN and MCM2-
7 complex, activating the CMG (CDC45-MCM2-7-GINS) helicase complex. 
Simultaneously, clamp loader RFC and sliding clamp PCNA are recruited and enable 
polymerases δ and ε to initiate replication in the lagging and leading strands 
respectively. B, when a replication fork is stalled, ssDNA is generated as the CMG 
complex unwinds DNA. ssDNA binds RPA that recruits ATR (through ATRIP), 
RAD17-RFC and 9-1-1 complexes at the stalled fork. ATR is then activated by 
TOPBP1/RAD17/9-1-1 and ETAA1 and phosphorylates Η2AX, while through 
TIMELESS/TIPIN/CLASPIN phoshoprylates CHK1. CHK1 then organises the RS 
response by arresting the cell cycle, inhibiting new origin firing, enabling dormant 
origin firing and stabilizing the fork, which can then be reversed by various proteins 
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in a chicken foot structure. An unprotected reversed fork is susceptible to nucleolytic 
degradation by MRE11, EXO1 and DNA2. A stalled fork can restart through 
homologous recombination, re-priming, template switching, translesion synthesis or 
break-induced replication. Alternatively, it will collapse into DSBs by the combined 
activity of MUS81-EME1, XPF-ERCC1, EXO1 and SLX4 that will drive the cell to 
senescence.  
 
Figure 2. Repair of a stalled fork. Upon encountering an obstacle, replication 
machine arrests and the CMG complex unwinds DNA ahead of the stalled fork, 
leaving ssDNA behind. Replication can resume through various mechanisms, such 
as translesion synthesis, template switching, re-priming, break-induced replication or 
homologous recombination. If this fails, the stalled fork is cleaved by MUS81-EME1 
during G2-phase and upon entrance in metaphase RAD52, POLD3 and MUS81-
SLX4 collaborate to facilitate replication of the under-replicated DNA through MiDAS. 
In the absence of MiDAS and during chromosomal segregation in anaphase, UFBs 
are formed at the CFSs, which will appear as micronuclei or 53BP1 bodies in the 
daughter cells. 
 
 
Figure 3. Oncogene-induced genomic instability. A, germline mutations in DNA 
repair genes lead to GIN. Activated oncogenes elicit genomic instability by causing 
defects in DNA repair, telomere erosion or replication stress; see text for details. B, 
activated oncogenes induce a multifaceted set of intertwined activities that 
deregulate fork progression leading to under-replicated DNA and genomic instability. 
In particular, through deregulation of the Rb/E2F pathway licensing factors are 
increased which instigates origin re-firing that decreases fork speed in response to 
head-to-tail fork collisions. Deregulation of CDK activity can decrease or increase 
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origin firing. In the first case, fork speed is initially increased, but the cell ends up 
with under-replicated DNA due to its inability to rescue endogenous RS by firing 
dormant origins. Increased origin firing raises the possibility of TRCs and 
simultaneously may cause depletion of dNTPs, histones or RPA. Oncogene-induced 
ROS either increase origin firing or oxidize nucleotides that potentially may affect 
fork progression. Oncogenes also increase transcription activity that either directly or 
through R-loops enhance TRCs. 
 
 
Figure 4. Transcription-associated replication stress. A, upon head-on conflicts 
between replication and transcription, R-loop formation is increased and ATR/CHK1 
are activated. B, upon co-directional conflicts between replication and a stalled or 
backtracked RNAP, DSBs are formed that activate ATM/CHK2 and R-loops are 
resolved. C, in response to any obstacle an RNAP may pause and backtrack and act 
as an impediment to fork progression; D, this can also occur as a result of an 
encounter with an R-loop. In both cases, this will cause accumulation of arrested or 
backtracked RNAPs that hinder fork progression. E, while the replication and 
transcription machineries move, positive supercoiling develops in front of them, that 
can impede progression of both. F, transcribed RNA may get trapped in the nuclear 
pore complex generating obstacles to fork progression. G, R-loops can cause 
chromatin condensation, marked by H3 phosphorylation at Ser-10, that impedes fork 
progression. H, G-quadruplexes can be formed co-transcriptionally or within the 
ssDNA part of an R-loop and act as obstacles to fork progression. 
 
 
Figure 5. Nucleotide and ROS metabolism as a cause of replication stress. dNTPs 
are formed either through the de novo pathway from glutamine, glycine, folic acid, 
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aspartate, 5-phosphoribosyl-1-pyrophosphate or by nucleoside degradation through 
the salvage pathway. The reduction of ribonucleosides to dNTPs is catalysed by the 
ribonucleotide reductase (RNR), which is compromised by two catalytic (RRM1) and 
two regulatory (RRM2, RRM2B) subunits. Oncogenes may target RNR activity or 
induce hyper-proliferation that will both reduce dNTP pool affecting fork progression. 
Oncogenes also induce production of ROS, including O2
ˉ, H2O2 and OH•. O2
ˉ is 
produced either by oxidation of NADPH by NOX enzymes or through aerobic 
respiration in mitochondria. H2O2 is generated by O2
ˉ which is converted by 
superoxide dismutase (SOD), while OH• are produced from H2O2 in the presence of 
Fe+2. It is not clear if oxidized dNTPs affect replication fork speed. 
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